IGK attenuates monoamine neurotransmitter deficiency and depression-like behaviors through downregulating the p38/NF-κB inflammatory signaling pathway (Li et al. 2021), and protects against obesity-induced cardiomyopathy (Wu et al. 2022). The gene discussed is NFKB1; the disease is obesity disorder.